Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 5 Lymphoma, T-Cell, Cutaneous 2 Vascular Malformations 1 Uterine Cervical Dysplasia 1 Surgical Wound Infection 1 Pilonidal Sinus 1 Pancreatic Neoplasms 1 Pain 1 Mycosis Fungoides 1 Keratosis 1 High-grade Anal Intraepithelial Neoplasia 1 Hemangioma, Capillary 1 Hemangioma 1 Head and Neck Neoplasms 1 Dermatitis, Contact 1 Condylomata Acuminata 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Cancer Lymphedema 1

Interventions

Cisplatin 253 Radiotherapy 176 Cetuximab 145 pembrolizumab 120 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 77 Radiotherapy, Intensity-Modulated 69 Nivolumab 37 Radiation 30 Drug Therapy 30 Erlotinib Hydrochloride 26 Gemcitabine 25 Cyclophosphamide 22 Gefitinib 21 Surveys and Questionnaires 20 Standard of Care 20 Surgical Procedures, Operative 19 Pemetrexed 19 durvalumab 18 Magnetic Resonance Spectroscopy 17 Capecitabine 17 Radiosurgery 16 Celecoxib 16 atezolizumab 15 Filgrastim 15 Amifostine 15 130-nm albumin-bound paclitaxel 15 fludarabine 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Ointments × Clear all

NCT01693159 2017-09-25

SUPPORT

National Center for Tumor Diseases, Heidelberg

Phase NA Unknown

Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡